EP1434625A2 - Verbesserte formulierungen zur neutralisation von chemischen, biologischen und technischen verbindungen - Google Patents

Verbesserte formulierungen zur neutralisation von chemischen, biologischen und technischen verbindungen

Info

Publication number
EP1434625A2
EP1434625A2 EP02775899A EP02775899A EP1434625A2 EP 1434625 A2 EP1434625 A2 EP 1434625A2 EP 02775899 A EP02775899 A EP 02775899A EP 02775899 A EP02775899 A EP 02775899A EP 1434625 A2 EP1434625 A2 EP 1434625A2
Authority
EP
European Patent Office
Prior art keywords
formulation according
formulation
water
reactive compound
bleaching activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP02775899A
Other languages
English (en)
French (fr)
Other versions
EP1434625A4 (de
EP1434625B1 (de
Inventor
Mark D. Tucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Technology and Engineering Solutions of Sandia LLC
Original Assignee
Sandia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandia Corp filed Critical Sandia Corp
Publication of EP1434625A2 publication Critical patent/EP1434625A2/de
Publication of EP1434625A4 publication Critical patent/EP1434625A4/de
Application granted granted Critical
Publication of EP1434625B1 publication Critical patent/EP1434625B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62DCHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/30Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62DCHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/30Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
    • A62D3/38Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents by oxidation; by combustion
    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62DCHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/30Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
    • A62D3/36Detoxification by using acid or alkaline reagents
    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62DCHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D2101/00Harmful chemical substances made harmless, or less harmful, by effecting chemical change
    • A62D2101/02Chemical warfare substances, e.g. cholinesterase inhibitors

Definitions

  • the present invention relates to formulations for neutralization of chemical, biological and industrial toxants.
  • the present invention is directed to materials and methods for neutralization of toxic chemical, biological and industrial compounds or agents, especially chemical and biological weapons agents, and methods of making same.
  • the present invention is directed to materials containing solubilizing compounds, reactive compounds and bleaching activators that can be delivered as foams, sprays, liquids, fogs and aerosols to enhance the rate of reactions leading to neutralization of chemical compounds, and other additives which serve to kill or attenuate certain biological compounds or agents.
  • Terrorist threats potentially involving weapons of mass destruction, are increasing both in the United States and abroad.
  • the use, and threat of use, of chemical and biological agents in the context of weapons of mass destruction are of paramount concern both to national defense as well as to state and local law enforcement.
  • the chemical agents sarin, soman, and tabun (G-agents) are all examples of phosphorus-containing compounds which, when altered chemically, can lose their toxicity.
  • Mustard which is an example of the H- agents
  • VX which is an example of the V-agents
  • BW agents include botulinum toxin, anthrax and other spore-forming bacteria, vegetative bacteria, including plague and various viruses can also be deactivated chemically.
  • a CW or biological warfare (“BW”) attack can involve either local placement or wide dispersal of the agent or agents so as to affect a population of human individuals. Because of the flexibility with which CW and BW (“CBW”) agents can be deployed, respondents might encounter the agents in a variety of physical states including bulk, aerosol and vapors.
  • BW biological warfare
  • An effective, rapid, and safe (non-toxic and non-corrosive) decontamination technology is required for the restoration of civilian facilities in the event of a domestic terrorist attack.
  • this technology should be applicable to a variety of scenarios such as the decontamination of open, semi- enclosed, and enclosed facilities as well as sensitive equipment.
  • Examples of types of facilities where the decontamination formulation may be utilized include a stadium (open), an underground subway station (semi-enclosed), and an airport terminal or office building (enclosed).
  • a foaming version is useful for extending the contact time of the formulation on vertical surface.
  • Decontamination of chemical compounds have focused primarily on chemical warfare agents, particularly on the nerve agents (such as G agents and V agents) and on the blistering agents (such as mustard gas, or simply, mustard). Reactions involved in detoxification of chemical agents can be divided into substitution and oxidation reactions. Decontamination of biological agents is primarily focused on bacterial spores (e.g., anthrax), which are considered to be the most difficult of all microorganisms to kill. Additional background is discussed in U.S. Patent Applications Serial Nos. 09/607,586 and 09/952,940.
  • U.S. Patent Application Serial No. 09/607,586 is related generally to an aqueous-based decontamination technology ("DF-100") that rapidly neutralizes chemical and biological warfare (“CBW”) agents.
  • DF-100 aqueous-based decontamination technology
  • CBW chemical and biological warfare
  • the formulation is effective for neutralizing both chemical and biological agents; • is environmentally benign (i.e., non-toxic and non-corrosive); works on a number of anticipated material surfaces; and can be incorporated into a wide variety of carriers (e.g., foams, liquid sprays, fogs) that satisfy a wide variety of operational objectives.
  • a major interest for the use of the technology was from the civilian first responder (e.g., fire departments, police departments, and HazMat units who would be the first to arrive at the scene of an attack utilizing CBW agents) followed by a secondary interest in use of the formulation for facility restoration.
  • DF-100A A modified formulation, DF-100A, disclosed in U.S. Patent Application Serial No. 09/952,940, addressed the requirement to adjust the pH for each specific agent (i.e., the first technical problem described above).
  • DF-100A does improve upon the performance of the formulation at a single pH, it does not completely solve this problem, and does not even address the second technical problem (i.e., the relatively slow reaction rate with Mustard).
  • some versions of DF-100/100A can use short-chain alcohols (e.g., isobutanol, isopropanol), which can cause flammability problems if the formulation is packaged in a concentrated form.
  • some versions of DF-100/100A can use diethylene glycol monobutyl ether (DEGMBE), which can cause false alarms on some chemical agent sensors and detectors (especially older sensors that are used in some military settings).
  • DEGMBE diethylene glycol monobutyl ether
  • This formulation can be adjusted to a pH value of 8 for optimal decontamination of Mustard and Anthrax spores; and can be adjusted to a pH value of 10.5 for optimal decontamination of VX.
  • Decontamination of chemical agents is generally effective anywhere between pH 8 and 10.
  • This formulation can be adjusted to a pH value of 8 for optimal decontamination of Mustard and Anthrax spores; and can be to a pH value of 10 for optimal decontamination of VX.
  • Decontamination of chemical agents is generally effective anywhere between pH 8 and 10. Also, it can be adjusted to a pH of 9.2 for less than optimal decontamination of all agents.
  • the hydrogen peroxide and bicarbonate salt react to produce a highly reactive negatively charged nucleophillic species, hydroperoxycarbonate (HC0 4 ), which is a strong oxidant.
  • hydroperoxycarbonate HC0 4
  • Other negatively-charged nucleophiles are formed by the use of hydrogen peroxide, including: hydroxyl ions (OH " ) and hydroperoxide ions (OOH " ).
  • OH hydroxyl ions
  • OOH " hydroperoxide ions
  • the present invention presents enhanced decontamination formulations (generically designated "DF-200") that include bleaching activators, which leads to faster reaction kinetics, improved performance, and the elimination of the need for pH adjustment.
  • bleaching activators are commonly used in (anionic) laundry detergents
  • the present invention can employ them with cationic surfactants, and where good solubility in water of the activator is useful for achieving quick reaction times.
  • a desirable bleaching activator for use in the present invention is preferably water-soluble, non-toxic, non-flammable, and low-cost.
  • Glucose pentaacetate is an O-acetyl peroxide activator that has been used as an activation agent in a sterilizing composition comprising a cationic surface-active agent and inorganic peroxide (See Japanese Laid-Open Patent Publication No. 62-155203, entitled “Sterilizing Composition for Cattle Shed” (1987)).
  • Glucose pentaacetate is a solid at room temperature (i.e., melting point 110 degrees C), and is insoluble in water. In an aqueous solution containing peroxide, it dissolves very slowly in water as it reacts with the peroxide. At a glucose pentaacetate concentration of about 2%, it takes several hours to dissolve.
  • the present inventions is of a formulation for use in neutralization of at least one toxant, comprising: at least two solubilizing compounds, wherein at least one solubilizing compound is a cationic surfactant and at least one solubilizing compound is a cationic hydrotrope; at least one reactive compound, wherein the at least one reactive compound is selected from the group consisting of hydrogen peroxide, urea hydrogen peroxide, hydroperoxycarbonate, peracetic acid, sodium perborate, sodium peroxypyrophosphate, sodium peroxysilicate, and sodium percarbonate; and at least one bleaching activator selected from the group consisting of O-acetyl, N-acetyl, and nitrile group bleaching activators; wherein the at least two solubilizing compounds, the at least one reactive compound, and the at least one bleaching activator, when mixed with water and exposed to the at least two solubilizing compounds, when mixed with water and exposed to the at least two solubilizing compounds, wherein at least one solub
  • the cationic surfactant comprises a quaternary ammonium salt, most preferably cetyltrimethyl ammonium bromide, benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, alkyldimethylbenzylammonium salt, tetrabutyl ammonium bromide, or WITCO VARIQUAT 80MCTM, or a combination thereof.
  • a quaternary ammonium salt most preferably cetyltrimethyl ammonium bromide, benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, alkyldimethylbenzylammonium salt, tetrabutyl ammonium bromide, or WITCO VARIQUAT 80MCTM, or a combination thereof.
  • the formulation may further comprise water-soluble polymer, preferably polyvinyl alcohol, guar gum, (cationic or non-ionic) polydiallyl dimethyl ammonium chloride, polyacrylamide, poly (ethylene oxide), glycerol, polyethylene glycol 8000 (PEG 8000), or JAGUAR 8000TM (Guar Gum 2-hydroxypropyl ether), or a combination thereof.
  • water-soluble polymer preferably polyvinyl alcohol, guar gum, (cationic or non-ionic) polydiallyl dimethyl ammonium chloride, polyacrylamide, poly (ethylene oxide), glycerol, polyethylene glycol 8000 (PEG 8000), or JAGUAR 8000TM (Guar Gum 2-hydroxypropyl ether), or a combination thereof.
  • the formulation may also further comprise a fatty alcohol comprising from 8 to 20 carbon atoms per molecule, a solvent (preferably Di(propylene glycol) methyl ether or diethylene glycol monobutyl ether or a combination thereof), and/or a carbonate salt (preferably potassium bicarbonate, sodium bicarbonate, ammonium bicarbonate, ammonium hydrogen bicarbonate, lithium bicarbonate, ammonium carbonate, or potassium carbonate, or a combination thereof).
  • a solvent preferably Di(propylene glycol) methyl ether or diethylene glycol monobutyl ether or a combination thereof
  • a carbonate salt preferably potassium bicarbonate, sodium bicarbonate, ammonium bicarbonate, ammonium hydrogen bicarbonate, lithium bicarbonate, ammonium carbonate, or potassium carbonate, or a combination thereof.
  • the bleaching activator is preferably water-soluble, most preferably acetylcholine chloride, monoacetin (glycerol monoacetate), diacetin (glycerol diacetate), 4-cyanobenzoic acid, ethylene glycol diacetate, propylene glycol monomethyl ether acetate, methyl acetate, dimethyl glutarate, diethylene glycol monoethyl ether acetate, glycerol diacetate (Diacetin), glycerol monoacetate, glycerol triacetate, or propylene glycol diacetate, or a combination thereof.
  • acetylcholine chloride monoacetin (glycerol monoacetate), diacetin (glycerol diacetate), 4-cyanobenzoic acid, ethylene glycol diacetate, propylene glycol monomethyl ether acetate, methyl acetate, dimethyl glutarate, diethylene glycol monoethyl ether acetate, glycerol dia
  • the bleaching activator may be water-insoluble, preferably tetraacetyl ethylenediamine (TAED), n-nonanoyloxybenzenesulfonate (NOBS), or N-acetyl glucosamine, or a combination thereof.
  • TAED tetraacetyl ethylenediamine
  • NOBS n-nonanoyloxybenzenesulfonate
  • N-acetyl glucosamine or a combination thereof.
  • the formulation when mixed with water, preferably has a pH value between about 9.6 and about 9.8.
  • One embodiment of the invention consists essentially of 1- 10% Benzalkonium Chloride, 1-8% Propylene Glycol Diacetate; 1-16% Hydrogen Peroxide; and 2- 8% Potassium Bicarbonate.
  • the invention is also of a formulation for use in neutralization of at least one toxant, comprising: at least one cationic surfactant; at least one reactive compound, wherein the at least one reactive compound is selected from the group consisting of hydrogen peroxide, urea hydrogen peroxide, hydroperoxycarbonate, peracetic acid, sodium perborate, sodium peroxypyrophosphate, sodium peroxysilicate, and sodium percarbonate; at least one bleaching activator selected from the group consisting of O-acetyl, N-acetyl, and nitrile group bleaching activators; and at least one carbonate salt not one of the at least one reactive compounds; wherein the at least one surfactant, the at least one reactive compound, the at least one bleaching activator, and the at least one carbonate salt, when mixed with water and exposed to the at least one toxant, neutralizes the at least one toxant.
  • the formulation when mixed with water, has a pH value between about 9.6 and about 9.8 and the cationic surfactant comprises a quaternary ammonium salt, most preferably benzalkonium chloride.
  • the at least one carbonate salt is preferably potassium bicarbonate, sodium bicarbonate, ammonium bicarbonate, ammonium hydrogen bicarbonate, lithium bicarbonate, ammonium carbonate, or potassium carbonate, or a combination thereof.
  • One embodiment consists substantially of the at least one cationic surfactant, the at least one reactive compound, the at least one bleaching activator, and the at least one carbonate salt.
  • the bleaching activator is preferably water-soluble, most preferably acetylcholine chloride, monoacetin (glycerol monoacetate), diacetin (glycerol diacetate), 4-cyanobenzoic acid, ethylene glycol diacetate, propylene glycol monomethyl ether acetate, methyl acetate, dimethyl glutarate, diethylene glycol monoethyl ether acetate, glycerol diacetate (Diacetin), glycerol monoacetate, glycerol triacetate, or propylene glycol diacetate, or a combination thereof.
  • acetylcholine chloride monoacetin (glycerol monoacetate), diacetin (glycerol diacetate), 4-cyanobenzoic acid, ethylene glycol diacetate, propylene glycol monomethyl ether acetate, methyl acetate, dimethyl glutarate, diethylene glycol monoethyl ether acetate, glycerol dia
  • the invention is further of a formulation for use in neutralization of at least one toxant, comprising: at least one cationic surfactant; at least one reactive compound, wherein the at least one reactive compound is selected from the group consisting of hydrogen peroxide, urea hydrogen peroxide, hydroperoxycarbonate, peracetic acid, sodium perborate, sodium peroxypyrophosphate, sodium peroxysilicate, and sodium percarbonate; and at least one water-soluble bleaching activator selected from the group consisting of O-acetyl, N-acetyl, and nitrile group bleaching activators; wherein the at least one surfactant, the at least one reactive compound, and the at least one water- soluble bleaching activator, when mixed with water and exposed to the at least one toxant, neutralizes the at least one toxant.
  • the at least one water-soluble bleaching activator is acetylcholine chloride, monoacetin (glycerol monoacetate), diacetin (glycerol diacetate), 4-cyanobenzoic acid, ethylene glycol diacetate, propylene glycol monomethyl ether acetate, methyl acetate, dimethyl glutarate, diethylene glycol monoethyl ether acetate, glycerol diacetate (Diacetin), glycerol monoacetate, glycerol triacetate, or propylene glycol diacetate, or a combination thereof.
  • the cationic surfactant preferably comprises a quaternary ammonium salt, most preferably benzalkonium chloride.
  • the formulation preferably further comprises at least one carbonate salt, most preferably potassium bicarbonate, sodium bicarbonate, ammonium bicarbonate, ammonium hydrogen bicarbonate, lithium bicarbonate, ammonium carbonate, or potassium carbonate, or a combination thereof.
  • the formulation when mixed with water, has a pH value between about 9.6 and about 9.8.
  • One embodiment consists substantially of the at least one cationic surfactant, the at least one reactive compound, and the at least one water-soluble bleaching activator.
  • the invention is yet further of a formulation for use in neutralization of at least one toxant, the formulation comprising: a t least one solubilizing compound, selected from the group consisting of a cationic hydrotrope and a fatty alcohol comprising from 8 to 20 carbon atoms per molecule; at least one reactive compound, wherein the at least one reactive compound is selected from the group consisting of hydrogen peroxide, urea hydrogen peroxide, hydroperoxycarbonate, peracetic acid, sodium perborate, sodium peroxypyrophosphate, sodium peroxysilicate, and sodium percarbonate; and at least one bleaching activator selected from the group consisting of O-acetyl, N-acetyl, and nitrile group bleaching activators; wherein the at least one solubilizing compound, the at least one reactive compound, and the at least one bleaching activator, when mixed with water and exposed to the at least one toxant, neutralizes the at least one toxant.
  • a t least one solubilizing compound
  • kits comprises: a premixed component comprising at least two solubilizing agents; a first component comprising at least one bleaching activator; and a second component comprising at least one reactive compound.
  • the first embodiment may further comprise water and a base
  • the premixed component may additionally comprise a water-soluble polymer
  • the at least one bleaching activator is preferably propylene glycol diacetate, glycerol diacetate, and/or TAED
  • the premixed component may additionally comprise a fatty alcohol comprising from 8 to 20 carbon atoms per molecule
  • the at least one reactive compound may be urea hydrogen peroxide with the second component comprising the at least one reactive compound additionally comprising sodium percarbonate
  • the premixed component may additionally comprise a short-chained alcohol.
  • a second embodiment comprises: a first premixed component comprising at least two solubilizing agents and water; and a second premixed component comprising at least one bleaching activator and the at least one reactive compound, wherein the at least one bleaching activator is in solid form.
  • the first premixed component preferably additionally comprises an acid
  • the at least one bleaching activator preferably comprises acetycholine chloride
  • the at least one reactive compound comprises urea hydrogen peroxide
  • the at least one bleaching activator comprises TAED
  • the at least one bleaching activator is encapsulated to prevent premature reaction with the at least one reactive compound.
  • a third embodiment comprises: a premixed component comprising at least two solubilizing agents and at least one bleaching activator; and a component comprising at least one reactive compound.
  • the premixed component may additionally comprise water and an acid
  • the component comprising the at least one reactive compound may comprise sodium percarbonate and additionally an acid
  • the at least one reactive compound may comprise urea hydrogen peroxide with the component comprising the at least one reactive compound additionally comprising a mixture of potassium carbonate and potassium bicarbonate.
  • Fig. 1 is a graph of the effect of DF-200 components on Bacillus globigii (anthrax simulant) spore kill;
  • Fig. 2 is a schematic diagram of a preferred mixing procedure for a first rapid deployment configuration of the present invention ("DF-200HF Rapid Deployment");
  • Fig. 3 is a schematic diagram of a preferred mixing procedure for a second rapid deployment ⁇ configuration of the present invention ("DF-200HF Slurry Rapid Deployment").
  • the present invention addresses the need for a general formulation that neutralizes the adverse effects of either or both chemical and biological toxants, where a toxant is defined as any chemical or biological compound, constituent, species, or agent that through its chemical or biological action on life processes can, if left untreated, cause death, temporary incapacitation, or permanent harm to humans or animals. This includes all such chemicals or biological agents, regardless of their origin or of their method of production, and regardless of whether they are produced in facilities, in munitions or elsewhere.
  • Neutralization is defined as the mitigation, detoxification, decontamination, or otherwise destruction of toxants to the extent that the toxants no longer cause acute adverse effects to humans or animals.
  • the formulation and described variations of the present invention can neutralize, and does not itself contain or produce, infection, significant adverse health effects, or even fatality in animals.
  • CW chemical warfare
  • BW biological warfare
  • the present invention also addresses toxants that can cause potential adverse health effects to animals, including humans, where such adverse health effects include infections, acute and chronic health effects, and fatalities.
  • Such toxants can be found in an agricultural facility, animal or dairy farm, or food products processing or packaging facility.
  • the present invention addresses the need for such a formulation that is itself non-toxic and non-corrosive, and that can be delivered by a variety of means and in different phases. Certain embodiments are discussed in U.S. Patent Applications Serial Nos. 09/607,586 and 09/952,940. The present invention presents additional embodiments that have substantial differences over both the prior art and the earlier embodiments, as will be described below.
  • formulation is defined herein as the activated product or solution (e.g., aqueous solution) that is applied to a surface or body for the purpose of neutralization, with or without the addition of a gas (e.g., air) to create a foam.
  • a gas e.g., air
  • concentrations, constituents, or components listed herein are relative to the weight percentage of the overall activated solution.
  • water is defined herein to broadly include: pure water, tap water, deionized water, demineralized water, saltwater, or any other liquid consisting primarily of H 2 0.
  • a minimum set of constituents for a DF-200 formulation that can achieve a significant rate of spore kill comprises four components:
  • a solubilizing agent selected from the group consisting of a cationic surfactant (e.g., sodium EDTA), sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium EDTA, sodium sulfate, sodium sulfate, sodium sulfate, sodium bicarbonate, sodium bicarbonate, sodium quaternary ammonium salt, sodium quaternary ammonium salt, sodium quaternary ammonium salt, sodium quaternary ammonium salt, sodium quaternary ammonium, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfit
  • Variquat 80MC a cationic hydrotrope (e.g., Adogen 477), and a fatty alcohol (e.g., 1- Dodeconal);
  • a beaching activator selected from the group consisting of O-acetyl, N-acetyl, and nitrile group peroxide activators (e.g., propylene glycol diacetate);
  • a reactive compound e.g., hydrogen peroxide, peracetic acid
  • the solubilizing agent serves to effectively render the toxant susceptible to attack, while the reactive compound serves to attack and neutralize the toxant, and the bleaching activator enhances the process.
  • Suitable cationic surfactants include: quaternary ammonium salts and polymeric quaternary salts.
  • suitable quaternary ammonium salts include: cetyltrimethyl ammonium bromide, benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, alkyldimethylbenzylammonium salt, and tetrabutyl ammonium bromide.
  • a preferred cationic surfactant is WITCO VARIQUAT 80MCTM, which is a mixture of benzyl (C12-C16) alkyldimethylammonium chlorides.
  • the concentration of quaternary ammonium salt used in DF-200 formulations is preferably no more than about 10%, because at higher concentrations the quaternary ammonium salt becomes significantly toxic to humans and the environment.
  • Suitable cationic hydrotropes include: tetrapentyl ammonium bromide, triacetyl methyl ammonium bromide, and tetrabutyl ammonium bromide.
  • a preferred cationic hydrotrope is WITCO ADOGEN 477TM, which is a pentamethyltallow alkyltrimethylenediammonium dichloride.
  • Suitable fatty alcohols include alcohols having 8-20 carbon atoms per molecule, such as: 1-dodecanol, pure dodecanol, hexadecanol, and 1-tetradecanol. Examples of suitable bleaching activators are discussed subsequently.
  • Suitable reactive compounds include: peroxide compounds; hydrogen peroxide; urea hydrogen peroxide; sodium perborate; sodium percarbonate; sodium carbonate perhydrate; sodium peroxypyrophosphate; sodium peroxysilicatehydrogen; peroxide adducts of pyrophosphates; citrates; sodium sulfate; urea; and sodium silicate; an activated peroxide compound (e.g., hydrogen peroxide + bicarbonate); peracetic acid; oximates (e.g., butane-2,3-dione, monooximate ion, and benzohydroxamate); alkoxides (e.g., methoxide and ethoxide); aryloxides (e.g., aryl substituted benzenesulfonates); aldehydes (e.g., glutaraldehyde); peroxymonosulfate; Fenton's reagent (a mixture of iron and peroxide); and sodium hypochlorit
  • hydroxyl ions (OH ) and hydroperoxide ions ((OOH ) produced when using hydrogen peroxide
  • hydroperoxycarbonate ions (HC0 4 " ) produced when hydrogen peroxide is combined with a carbonate salt.
  • Hydroperoxycarbonate ions (HC0 ) are a much stronger oxidant than hydroxyl ions (OH ) or hydroperoxide ions ((OOH ), and are especially effective in reacting with biological toxants.
  • its concentration is preferably less than about 10% because higher concentrations are significantly corrosive, especially in the range of 30-50% hydrogen peroxide concentration.
  • a carbonate salt e.g., sodium bicarbonate or potassium bicarbonate
  • a peroxide compound e.g., hydrogen peroxide
  • the added carbonate salt combines with, e.g., hydrogen peroxide to form the highly reactive hydroperoxycarbonate species (HC0 4 ).
  • Addition of carbonate salts can also buffer the formulation to optimize the pH.
  • a minimum set of constituents for DF-200 formulations that can achieve a very high rate of spore kill can comprise five components: (1) a solubilizing agent selected from the group consisting of a cationic surfactant (e.g.,
  • Variquat 80MC a cationic hydrotrope (e.g., Adogen 477), and a fatty alcohol (e.g., 1- Dodeconal);
  • a beaching activator selected from the group consisting of O-acetyl, N-acetyl, and nitrile group peroxide activators (e.g., propylene glycol diacetate);
  • a reactive component e.g., hydrogen peroxide, peracetic acid, etc.
  • a carbonate salt e.g., sodium bicarbonate
  • suitable carbonate salts include: potassium bicarbonate, sodium bicarbonate, ammonium bicarbonate, ammonium hydrogen bicarbonate, lithium bicarbonate, ammonium carbonate, and potassium carbonate.
  • Figure 1 shows the results of decontamination tests on Bacillus globigii spores (initial concentration 10 7 spores/ml). The spores were exposed to four different sub-combinations of the various components of DF-200 formulations for 1 hour (the pH of the formulation was 9.8). The degree of spore kill was determined by culturing surviving organisms.
  • spore kill was achieved by using a third combination, comprising (3) an aqueous solution of 2% Variquat (a cationic surfactant), 2% propylene glycol diacetate (bleaching activator), 5% potassium bicarbonate (buffer and peroxide activator) and 2% hydrogen peroxide (oxidant).
  • Variquat a cationic surfactant
  • propylene glycol diacetate a cationic surfactant
  • potassium bicarbonate buffer and peroxide activator
  • hydrogen peroxide oxidant
  • DF-200HF Hi ⁇ h Foam
  • the present invention provides an enhanced decontamination formulation for high foam applications ("DF-200HF").
  • DF-200HF an enhanced decontamination formulation for high foam applications
  • An example of a formulation for DF-200HF comprises:
  • Variquat 80MC cationic surfactant
  • Adogen 477 cationic hydrotrope
  • 1 -Dodecanol fatty alcohol
  • Jaguar 8000 cationic water-soluble polymer
  • Bicarbonate salt buffer and peroxide activator
  • This formulation is effective at a pH value between 7.5 and 10.5. This formulation can be adjusted to a pH value between 9.6 and 9.8 for optimal decontamination of all target agents.
  • This "high-foam” formulation includes a cationic water-soluble polymer (e.g., Jaguar 8000TM), which increases the bulk viscosity of the solution and produces a more stable foam.
  • non-anionic water-soluble polymers examples include: polyvinyl alcohol, guar gum, (cationic or non-ionic) polydiallyl dimethyl ammonium chloride, polyacrylamide, polyethylene glycol 8000 (PEG 8000), and JAGUAR 8000TM (Guar Gum 2-hydroxypropyl ether).
  • a cationic polymer is preferred over a non-ionic polymer; an anionic polymer does not work well.
  • the fatty alcohol 1 -dodecanol serves to increase the surface viscosity of the foam lamellae to also increase foam stability against drainage and bubble collapse.
  • DF-200LF Low Foam
  • the present invention provides an enhanced decontamination formulation for low foam applications ("DF-200LF").
  • DF-200LF an enhanced decontamination formulation for low foam applications
  • An example of a formulation for DF-200LF comprises:
  • This formulation is generally effective at a pH value between 7.5 and 10.5. This formulation can be adjusted to a pH value between about 9.6 and 9.8 for optimal decontamination of all target agents.
  • 'High Foam' refers to the ability of a formulation to form a highly stable and persistent foam, whereas a 'Low Foam' formulation forms a much less stable foam.
  • the following tables show the improved performance of DF-200HF and DF-200LF as compared to DF-100A.
  • the notation "ND” refers to a concentration below detectable limits, and "PGD” refers to propylene glycol diacetate (a preferred bleaching activator).
  • Table 1 Summary of the reaction rates for Mustard simulant (2-Chloroethyl phenyl sulfide).
  • Differences between formulations of DF-200 and DF-100/100A include:
  • DF-200 is active against all agents at a single pH.
  • the formulation is effective at pH values between about 7.5 and 10.5; is more effective at pH values between about 9.2 and 9.8; and is most effective at pH values between about pH 9.6 and 9.8; • DF-200 has better performance against Mustard;
  • DF-200 has better performance against bacterial spores
  • DF-200 has lower concentrations of both the cationic surfactant and/or the cationic hydrotrope, which further lowers the (already low) toxicity and corrosivity properties of the formulation; • DF-200 has a lower concentration of the foam stability component, 1 -Dodecanol;
  • DF-200 doesn't use a short-chained alcohol (e.g., isobutanol, isopropanol), which causes flammability problems when the formulation is packaged in a concentrated form;
  • a short-chained alcohol e.g., isobutanol, isopropanol
  • DF-200 doesn't use Diethylene Glycol MonoButyl Ether (DEGMBE), which can cause false alarms on some chemical agent sensors and detectors (especially older sensors which are used in some military settings); and
  • DEGMBE Diethylene Glycol MonoButyl Ether
  • DF-200 can contain a lower concentration of hydrogen peroxide, which also reduces the (already low) toxicity and corrosivity properties of the formulation.
  • DF-200 performs optimally at a higher pH (about 9.6 to 9.8) as compared to DF-
  • DF-200 has more individual components that should be stored separately (e.g, the hydrogen peroxide and the bleaching activator) from the bulk formulation until use, as compared to DF-100A (where only one component, hydrogen peroxide, should be stored separately). This will be discussed in greater detail below.
  • DF-200 formulations e.g., DF-200HF and DF-200LF
  • DF-100A formulations DF-100A formulations
  • a bleaching activator e.g., propylene glycol diacetate
  • Bleaching activators can be compounds with O- or N- bounded acetyl groups that react with the strongly nucleophilic hydroperoxy anion (OOH " ) to yield peroxygenated species, which are more efficient oxidizers than hydrogen peroxide alone.
  • TAED and NOBS bleaching activators are extremely insoluble in water (e.g., TAED is only 0.1% soluble at 25°C). To get around this problem in a laundry detergent, the solid TAED or NOBS particles are kept in suspension by the agitating action of the washing machine, where they slowly react with the hydrogen peroxide in the detergent.
  • agitation in the field of DF-200 formulations presents practical problems; hence, a water-soluble bleaching activator is preferred.
  • Useful water-soluble bleaching activators include short-chained organic compounds that contain an ester bond, e.g., ethylene glycol diacetate, propylene glycol monomethyl ether acetate, methyl acetate, dimethyl glutarate, diethylene glycol monoethyl ether acetate, glycerol diacetate (Diacetin), glycerol monoacetate, glycerol triacetate, and propylene glycol diacetate.
  • a preferred water-soluble bleaching activator is propylene glycol diacetate (PGD), which is shown below. O CH 3 O II
  • This molecule reacts with hydroperoxy anions (OOH " ), giving up the ester bonds to form two peroxygenated molecules.
  • Propylene glycol diacetate also acts as an organic solvent that is highly effective in solubilizing insoluble organic molecules (e.g., chemical warfare agents, as well as foam stabilizers/boosters (such as 1 -dodecanol and Lauramide DEA)). Therefore, an added function of this compound is that it can be used to supplement the diethylene glycol monobutyl ether (DEGMBE) solvent that is used in DF-100 and DF-100A, or to supplement the Di(propylene glycol) methyl ether solvent used in some DF-200 formulations, thereby allowing the propylene glycol diacetate to serve a dual purpose (i.e., solvent and bleaching activator).
  • DEGMBE diethylene glycol monobutyl ether
  • Di(propylene glycol) methyl ether solvent used in some DF-200 formulations
  • Bleaching activators are generally not stable in water for long periods of time. This is especially true when the aqueous solution is at a high pH (>10). Therefore, for long shelf life, the propylene glycol diacetate (or other bleaching activator) is preferably stored separate from the aqueous solution until use. This is not unlike other products that utilize bleach activators (e.g., laundry detergents), where all the components of the formulation are kept dry and separated until use (in the case of laundry detergent, the bleaching activator is encapsulated to prevent it from reacting with the peroxide component until both components are mixed in water).
  • bleach activators e.g., laundry detergents
  • ethylene glycol diacetate Another example of a water-soluble bleaching activator is ethylene glycol diacetate, which works well in DF-200 formulations. However, when ethylene glycol diacetate reacts with hydrogen peroxide, it forms ethylene glycol (i.e., anti-freeze), which is a relatively toxic byproduct. Propylene glycol diacetate, on the other hand, does not form this relatively toxic byproduct.
  • DF-200NF Non-Foaming
  • the present invention is also of a non-foaming embodiment (“DF-200NF") that may be used for specific applications, e.g., the kill of biological organisms, batch processing (such as in chemical agent demilitarization neutralization processes, i.e., in a bath of solution), or spray applications.
  • DF-200NF non-foaming embodiment
  • a preferred example of this formulation comprises (amounts illustrative):
  • DF-200NF Non-Foaming 1-10% (preferably 2.5%) Benzalkonium Chloride (cationic surfactant) 1-8% Propylene Glycol Diacetate (bleaching activator) 1-16% Hydrogen Peroxide (oxidant) 2-8% Potassium Bicarbonate (buffer and peroxide activator) 65.5-93.5% Water
  • the formulation can be adjusted to a pH value between about 9.6 and 9.8 for optimum performance, and is effective for decontamination of all target agents.
  • DF-100E The present invention is also of an enhanced version of DF-100A that utilizes the propylene glycol diacetate bleaching activator.
  • a preferred embodiment of this enhanced formulation, (“DF- 100E") comprises (amounts illustrative):
  • Table 5 Summary of the reaction rates for the DF-100E formulation in kinetic testing.
  • 2-part, 3-part, and 4-part “kit” configurations are shown for the different embodiments of DF-200 formulations.
  • the 2-part and 3-part kits have the bulk of the water already "pre-packaged” in one of the two (or three) containers (usually the foam component). This allows for rapid deployment of the decontamination solution, the use of small-scale units (e.g., backpacks), and doesn't require any extra water to be provided in the field.
  • the 4-part kits generally require that the make-up water is added in the field at, or near, the site of contamination. This allows the "package" containing the other three parts to be much lighter, which makes it easier to ship and store. However, a source of make-up is required in the field (which can be saltwater).
  • the DF-200 formulations can be configured either way, with the bulk of the water "pre-packaged", or without, depending on the application.
  • the DF-200HF formulation can be configured as a 4-part kit, and then prepared for field use as follows (amounts illustrative):
  • the bulk of the water is not included in the "package" (i.e., Parts A, B, and C), which minimizes the weight of the package for shipping and storage.
  • the make-up water (Part D) would be supplied in the field at, or near, the site of contamination.
  • the pH of the formulation can be adjusted to be between about 9.6 and 9.8 for optimal performance.
  • the formulation as described above will produce 1 liter of "high" foam solution.
  • sodium percarbonate supplies a portion of the hydrogen peroxide, a portion of the bicarbonate, and a base for buffering the solution.
  • the remainder of the hydrogen peroxide is supplied by the urea hydrogen peroxide.
  • the total hydrogen peroxide concentration is approximately 3% in this example.
  • the viscosity of the formulation can be adjusted to be between about 4-9 mm 2 /s.
  • Method 1 Supply the make-up water (Part D). Then, mix Part B into Part D. Then, add Parts C and A to Part B+D. Use, preferably, within 8 hours.
  • Method 2 Mix Part C into Part A. Supply the make-up water (Part D). Then, mix Part B into Part D. Keep separate until use. When use is required, mix Part A+C into Part B+D. Use, preferably, within 8 hours of first mixing Parts A+C into Parts B+D.
  • activated DF-200 formulations are used preferably within 8 hours after mixing, however, they still can be effective for up to 24 hours and longer.
  • DF-200HF High Foam
  • DF-200LF Low Foam
  • DF-200LF Low Foam
  • DF-200LF Low Foam
  • it can be applied to a surface, left for a relatively short period of time (e.g., 15-60 minutes), and then rinsed off with a high pressure freshwater or salt water spray.
  • Saltwater can also be effectively used as the make-up water (Part D) for DF-200 formulations.
  • Part D The table below shows the results of kinetic tests using DF-200HF (2% PGD / 3.50% H 2 0 2 / 4.0%) Bicarbonate salt) with saltwater ( ⁇ 35,000 ppm total dissolved solids):
  • Insoluble bleach activators such as TAED, NOBS, and N-acetyl glucosamine
  • TAED TAED
  • NOBS NOBS
  • the formulation results in a slurry when mixed with water, instead of a true aqueous solution.
  • the present invention also provides a method to utilize a water-insoluble solid bleach activator (e.g., TAED) to produce a reactive slurry (wherein a slurry is defined as a watery mixture that includes insoluble, undissolved matter).
  • a slurry is defined as a watery mixture that includes insoluble, undissolved matter.
  • DF-200HF Slurry is a modification of the DF-200HF formulation.
  • An example of a 4-part kit configuration is shown below (amounts illustrative):
  • DF-200HF Slurry (4-part kit) Part A (Foam Concentrate): 20 g Variquat 80MC 10 g Adogen 477 4 g 1 -Dodecanol
  • the formulation as described above will produce 1 liter of foam solution.
  • the pH of the final formulation can be adjusted to be between about 9.6 and 9.8 for optimal performance.
  • the following mixing procedure can be used: Mix Part B into Part D. Then, add Parts C and A to Parts B+D. Use, preferably, within 8 hours.
  • Table 9 Summary of the reaction rates for the DF-200HF Slurry formulation in kinetic testing. Note that improved performance can be achieved by using higher concentrations of TAED (e.g., 2% TAED, instead of 1 % TAED).
  • DF-200 would typically be used in large- scale operations where dedicated deployment equipment and a source of make-up water is readily available (e.g., for use by the military to decontaminate 'fixed sites' such as airbases and seaports), or used to minimize the volume of 'pre-packaged' water in order to minimize the weight of the formulation that needs to be shipped and stored.
  • the present invention is also of configurations emphasizing the rapid deployment of DF-200 formulations, and/or its deployment using small-scale deployment equipment (such as hand-held units, backpack units, or units mounted on small dollies). For these applications, all of the water is 'pre-packaged' into the formulation, so that no extra water is required in the field.
  • a first example of a 3-part kit configuration for a Rapid Deployment version of DF-200HF, "DF-200HF Rapid Deployment #1”, comprises (amounts illustrative):
  • DF-200HF Rapid Deployment #1 (3-part kit) Part A (Liquid Foam Component): 20 g Variquat 80MC 10 g Adogen 477
  • the pH of the final formulation can be adjusted to be between about 9.6 and 9.8 for optimal performance.
  • the following mixing procedure can be used: Mix Part B into Part A. After dissolution of the urea hydrogen peroxide, add Part C to Part A+B. Use, preferably, within 8 hours.
  • the performance of DF-200HF Rapid Deployment against chemical agent simulants is shown below in Table 10:
  • Table 10 Reaction rates from kinetic testing of DF-200HF Rapid Deployment #1 configuration.
  • FIG. 2 A schematic example of a preferred mixing procedure for this first example of a rapid deployment configuration of DF-200HF is shown in Figure 2.
  • Urea hydrogen peroxide dissolves rapidly in water. Therefore, the formulation can be prepared and deployed in a very short time at the scene of an incident involving chemical or biological warfare agents, making it ideal for use by civilian first responders (firefighters, HazMat units, police officers, and others who would be the first to arrive at the location of a CBW attack), and/or the military.
  • the particular bleaching activator (propylene glycol diacetate) used in this formulation is not stable in an aqueous solution where the pH is greater than approximately 9.9. Therefore, it is important to mix the right components in the correct order. For example, if Part C is mixed into Part A before the addition of Part B, there may be some loss of activity in DF-200HF since the propylene glycol diacetate is exposed to a solution having a pH value >9.9. This is not true, however, if Part B is added to Part A before the addition of Part C, since the addition of Part B to Part A brings the pH of the Part A+B mixture to a value below about 9.9.
  • the solvent, diethylene glycol monobutyl ether, used in Part A (the foam solution) of the first example shown above for DF-200HF Rapid Deployment #1 is different than the solvent that was used in the previously described DF-200HF formulation (Di(propylene glycol) methyl ether), because Di(propylene glycol) methyl ether is not stable in the high pH environment required for the foam component (Part A) in the rapid deployment configuration. Also, note that a short-chained alcohol (i.e., isobutanol) has been added to the foam component (Part A) in the rapid deployment configuration #1 of DF-200HF.
  • a short-chained alcohol i.e., isobutanol
  • a preferred formulation for DF-200HF Rapid Deployment #1 comprises:
  • Variquat 80MC cationic surfactant
  • Adogen 477 cationic hydrotrope 0.2-0.8% (preferably 0.4%) 1 -Dodecanol (fatty alcohol)
  • the formulation can be adjusted to a pH value between about 9.6 and 9.8 for optimal performance, and is effective for decontamination of all target agents.
  • a second example of a 3-part kit configuration for a Rapid Deployment version of DF-200HF, "DF-200HF Rapid Deployment #2”, comprises (amounts illustrative):
  • DF-200HF Rapid Deployment #2 (3-part kit) Part A (Liquid Foam Component): 20 g Variquat 80MC 10 g Adogen 477 4 g 1 -Dodecanol
  • Polyethylene Glycol 8000 polymer replaced the poly (Ethylene Oxide) polymer used in DF-200HF Rapid Deployment #1.
  • DF-200HF Rapid Deployment #3 comprises (amounts illustrative):
  • DF-200HF Rapid Deployment #3 (3-part kit) Part A (Liquid Foam Component): 20 g Variquat 80MC 10 g Adogen 477 4 g 1 -Dodecanol
  • Part B Solid Oxidant Component
  • Polyethylene Glycol 8000 polymer replaced the poly (Ethylene Oxide) polymer used in DF-200HF Rapid Deployment #1 as a water-soluble polymer.
  • Hexylene Glycol replaced Diethylene Glycol Monobutyl Ether and Isobutanol used as a solvents.
  • Glycol Diacetate i.e., Diacetin replaced Propylene Glycol Diacetate used as the bleaching activator.
  • the present invention is also of a 2-part kit configuration of a rapid deployment embodiment of the DF-200HF Slurry embodiment ("DF-200HF Slurry Rapid Deployment"), in which TAED (or other solid peroxide activator) is utilized as the bleaching activator.
  • DF-200HF Slurry Rapid Deployment a rapid deployment configuration of the DF-200HF Slurry embodiment
  • TAED solid peroxide activator
  • Part A (Liguid Foam Component):
  • Part B Solid Oxidant and Bleaching Activator
  • This formulation will produce 1 liter of foam solution.
  • the pH of the final formulation can be adjusted to be between 9.6 and 9.8 for optimal performance.
  • the following procedure can be used to mix the formulation: Mix Part B into Part A. Then, wait for at least one minute before use to allow time for the TAED to react with the hydrogen peroxide. Use, preferably, within 8 hours. It is useful to note that TAED will not immediately dissolve in water, but will remain as solid particles for at least 15-20 minutes. Therefore, a filter or screen may be required so that the undissolved TAED particles will not damage or clog any pumps or other components of the deployment device. However, the formulation is ready for use approximately 1 minute after addition of the TAED particles in Part B to Part A.
  • TAED it is useful to employ an encapsulated form of TAED in this configuration for two reasons.
  • the protective coating (which slowly dissolves in water) will protect the TAED so that it will not react with the urea hydrogen peroxide during storage.
  • the coating will protect the TAED from the high pH conditions in Part A until the urea hydrogen peroxide dissolves and lowers the pH of the formulation to a value below approximately 9.9.
  • TAED should be used in a similar manner as propylene glycol diacetate with respect to protecting the activator against exposure to high pH solutions.
  • TAED will lose much of its effectiveness as a bleaching activator if it is exposed to solutions with a pH greater than 9.9. Therefore, the use of an encapsulated form of TAED will minimize its exposure to the high pH conditions immediately after Part B is mixed into Part A.
  • Table 11 The performance of DF-200HF Slurry Rapid Deployment against chemical agent simulants is given in Table 11 below.
  • the present invention is also of a method for preparing the foam component (Part A) of the rapid deployment configurations.
  • Part A foam component
  • the invention is also of the following alternative DF-200 formulations:
  • An alternative formulation that includes a corrosion inhibitor 3.
  • Table 12 Reaction rates from kinetic testing for DF-200HF with propylene glycol (first example).
  • This configuration also incorporates the bleaching activator, propylene glycol diacetate, into the foam component Part A (rather than storing it as a separate, third component). This is possible because the pH of the foam component is less than 3. Propylene glycol diacetate will hydrolyze in solutions of pH greater than 3, but is hydrolytically stable in solutions of pH less than 3.
  • This configuration also uses the polyethylene glycol polymer (PEG 8000) for viscosity enhancement. This polymer is used in many cosmetics and is extremely soluble and stable in water. In addition, it is easier to mix into solution than Jaguar 8000 or a high molecular weight poly(ethylene oxide), since it does not have the tendency to clump.
  • PEG 8000 polyethylene glycol polymer
  • This configuration includes propylene glycol as a freeze-point depressant.
  • Propylene glycol is considered to be an environmentally friendly antifreeze. In this case, the concentration is approximately 15% by weight, which lowers the freezing point of Part A to approximately -20°C.
  • This configuration has also been tested with good results with propylene glycol concentrations as high as 40% by weight.
  • This formulation will produce 1 liter of foam solution.
  • the pH of the final formulation can be adjusted to be between about 9.6 and 9.8 for optimal performance.
  • the following mixing procedure can be used: Mix Part B into Part A. Use, preferably, within 8 hours.
  • sodium bisulfate a common pool conditioning chemical
  • citric acid can be used in place of citric acid to adjust the pH.
  • Table 13 The performance of this second example of DF-200HF with Proplyene Glycol (utilizing sodium percarbonate) against chemical agent simulants is shown in Table 13.
  • sodium percarbonate dissolves much more slowly than urea hydrogen peroxide after it has been added to Part A.
  • sodium percarbonate can be milled to approximately a 100 mesh size for use in this configuration. The time to dissolve the sodium percarbonate was decreased from approximately 30 minutes to about 2 minutes when milled sodium percarbonate was used.
  • Corrosion inhibitors can be added to DF-200 formulations to reduce their corrosivity.
  • a preferred corrosion inhibitor for use in DF-200 formulations is N,N-dimethyl ethanolamine.
  • other corrosion inhibitors such as triethanolamine, ethanolamine salts of C9, C10, and C12 iacid mixtures, dicyclohexyl amine nitrite, and N,N-dibenzylamine, can be used.
  • the Corrosion inhibitors added to DF-200 formulations can serve multiple purposes:
  • An example of a 3-part kit configuration of DF-200HF with a corrosion inhibitor comprises (amounts illustrative):
  • DF-200HF Rapid Deployment with Corrosion Inhibitor (3-part kit) Part A (Liquid Foam Component): 20 g Variquat 80MC 10 g Adogen 477 4 g 1 -Dodecanol
  • Part B Solid Oxidant Component
  • This formulation will produce 1 liter of foam solution.
  • the pH of the final formulation can be adjusted to be between about 9.6 and 9.8 for optimal performance.
  • the following mixing procedure can be used: Mix Part B into Part A. Then, after dissolution of the urea hydrogen peroxide, add Part C to Part A+B. Use, preferably, within 8 hours.
  • the performance of DF-200HF with corrosion inhibitor is shown below against chemical agent simulants is given in Table 14.
  • Table 14 Reaction rates in kinetic testing for DF-200HF with a corrosion inhibitor.
  • glycerol may be employed as a viscosity builder in place of Jaguar 8000, poly (ethylene oxide), or polyethylene glycol.
  • Glycerol is a common ingredient in cosmetics, where it is used a viscosity builder, as well as a solvent, humectant and emollient.
  • the use of glycerol in DF-200 formulations can serve multiple purposes: 1. Viscosity builder,
  • a humectant i.e., a substance which moisturizes the skin
  • An example of a 3-part kit configuration of DF-200HF with glycerol comprises (amounts illustrative):
  • This formulation will produce 1 liter of foam solution.
  • the pH of the final formulation can be adjusted to be between about 9.6 and 9.8 for optimal performance.
  • the following mixing procedure can be used: Mix Part B into Part A. Then after dissolution of the urea hydrogen peroxide, add Part C to Part +/B. Use, preferably, within 8 hours.
  • the performance of DF-200HF with glycerol against chemical agent simulants is given in Table 15.
  • This formulation can be used for direct application to humans because the glycerol will act as a humectant.
  • This formulation could also be utilized, e.g., as a spray or shower, by removing foaming constituents (such as 1 -dodecanol and Adogen 477), and by reducing the concentration of peroxide.
  • foaming constituents such as 1 -dodecanol and Adogen 477
  • concentration of peroxide e.g., a drawback to the use of glycerol is that it is solid at a fairly high temperature (below about 10°C). Therefore, it would preferably be used in controlled temperature conditions (i.e., warm temperature conditions).
  • Propylene glycol diacetate, a bleaching activator used in many of the previously described DF-200 configurations is not presently available in solid form. However, other bleaching activators are available in solid form.
  • Solid O-acetyl bleaching activators e.g., acetylcholine chloride, which is often used in eyedrop solutions
  • acetylcholine chloride which is often used in eyedrop solutions
  • DF-200 formulations in place of (liquid) propylene glycol diacetate.
  • the chemical structure of this O-acetyl bleaching activator is shown below. As can be seen, the molecule contains an O-acetyl group that can activate peroxide, and it is a quaternary compound, which is very compatible with DF-200 formulations.
  • Acetylcholine chloride is also soluble in water and is very hygroscopic.
  • An example of a 2-part kit configuration of DF-200HF using acetylcholine chloride comprises (amounts illustrative):
  • This formulation will produce approximately 1 liter of foam solution.
  • the pH of the final formulation can be adjusted to be between about 9.6 and 9.8 for optimal performance.
  • mix Part B into Part A Use, preferably, within 8 hours.
  • the performance of DF-200HF using acetylcholine chloride against chemical agent simulants is shown in Table 16.
  • Table 16 Reaction rates from kinetic testing for the DF-200HF using acetylcholine chloride as an activator.
  • DF-200 using Peracetic Acid Tests were conducted using peracetic acid as the oxidant in DF-200, instead of hydrogen peroxide.
  • the following formulation was used:
  • Variquat 80MC cationic surfactant
  • peracetic acid oxidant
  • potassium bicarbonate buffer and activator
  • Variquat 80MC cationic surfactant
  • oxidant oxidant
  • potassium bicarbonate buffer and activator
  • the pH was adjusted to 9.8 with solid KOH and the formulation was tested against the simulants for mustard, VX, and anthrax spores.
  • the performance of this formulation is shown in Table 18 against chemical agent simulants.
  • Table 18 Reaction rates in kinetic testing for DF-200 with 3.5% peracetic acid.
  • Tests were also conducted to determine the minimum constituents required for spore kill in a DF-200 formulation which utilizes peracetic acid as an oxidant. These results indicate that only three constituents, i.e., peracetic acid, bicarbonate and the cationic surfactant, are necessary to achieve high rates of spore kill.
  • Results of tests against anthrax spores is shown in Tables 20 and 21 and against Yersinia pestis (i.e., the plague bacterium) are shown in Table 22 (NG refers to 'no growth').
  • the detection limit for these tests were 10 CFU/ml. Note that the 'error bars' in the '% Reduction' column takes into account this detection limit.
  • Table 20 Kill rates for B. anthracis AMES-RIID spores in a solution of DF-200HF.
  • Table 22 Kill rates for Y. pestis cells in a solution of DF-200HF.
  • the petri dishes used for cell growth on each of these tests were saved for 21 days following the tests to verify that DF-200HF had actually killed the spores, rather than just inhibiting their growth. No growth on any of the petri dishes was observed after the 21 -day period.
  • TICs toxic industrial chemicals
  • Table 23 A summary of the TICs tested to date and the results of those tests is shown in Table 23. Note that the results for malathion, butyl isocyanate, sodium cyanide, and carbon disulfide were obtained by analyzing for the unreacted chemical in foam solution, while the results for phosgene was obtained by analyzing for the chemical in the headspace above a foam solution. These results demonstrate very effective neutralization of these toxic industrial chemicals.
  • Table 23 Summary of Toxic Industrial Chemical (TIC) Neutralization Tests with DF-200HF.
EP02775899.4A 2001-10-01 2002-09-20 Verbesserte formulierungen zur neutralisation von chemischen, biologischen und technischen verbindungen Expired - Lifetime EP1434625B1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US32650801P 2001-10-01 2001-10-01
US326508P 2001-10-01
US33427101P 2001-11-30 2001-11-30
US334271P 2001-11-30
US38710402P 2002-06-07 2002-06-07
US387104P 2002-06-07
PCT/US2002/029886 WO2003028429A2 (en) 2001-10-01 2002-09-20 Enhanced formulations for neutralization of chemical, biological and industrial toxants

Publications (3)

Publication Number Publication Date
EP1434625A2 true EP1434625A2 (de) 2004-07-07
EP1434625A4 EP1434625A4 (de) 2010-07-21
EP1434625B1 EP1434625B1 (de) 2018-07-18

Family

ID=27406465

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02775899.4A Expired - Lifetime EP1434625B1 (de) 2001-10-01 2002-09-20 Verbesserte formulierungen zur neutralisation von chemischen, biologischen und technischen verbindungen

Country Status (12)

Country Link
EP (1) EP1434625B1 (de)
JP (1) JP4582514B2 (de)
KR (1) KR100916328B1 (de)
CN (1) CN1612766B (de)
AU (1) AU2002341750B2 (de)
BR (1) BR0213019B1 (de)
CA (1) CA2461872C (de)
EA (1) EA009242B1 (de)
HK (1) HK1073618A1 (de)
IL (2) IL161200A0 (de)
MX (1) MXPA04003037A (de)
WO (1) WO2003028429A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3337325A4 (de) * 2015-07-17 2019-02-13 Next Science IP Holdings Pty Ltd Antimikrobielle zusammensetzung mit wirksamkeit gegen endosporen

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1928946A2 (de) 2005-01-11 2008-06-11 Clean Earth Technologies, LLC Formulierungen zur dekontamination toxischer chemikalien
EP1851271A1 (de) * 2005-01-11 2007-11-07 Clean Earth Technologies, LLC Persäure/peroxid-zusammensetzung und verwendung davon als antimikrobielles mittel und photosensibilisator
US9724550B2 (en) 2006-08-15 2017-08-08 American Sterilizer Company One part, solids containing decontamination blend composition
US9700644B2 (en) 2006-08-15 2017-07-11 American Sterilizer Company One part, solids containing decontamination blend composition
US20120141598A1 (en) * 2008-10-08 2012-06-07 Jessie Kater Broad spectrum decontaminate and dispersement system
US8969283B2 (en) * 2009-02-05 2015-03-03 American Sterilizer Company Low odor, hard surface sporicides and chemical decontaminants
RU2484868C2 (ru) * 2009-04-24 2013-06-20 Ольга Анатольевна Афанасьевская Комплексная, безотходная переработка токсичных отходов
US20110177145A1 (en) * 2009-07-27 2011-07-21 E.I. Du Pont De Nemours And Company In situ preparation of peracid-based removable antimicrobial coating compositions and methods of use
GB201010374D0 (en) 2010-06-21 2010-08-04 Mtp Innovations Ltd Disinfectant composition
CN107072216B (zh) 2014-09-09 2023-02-28 阿萨达有限责任公司 含有季铵化合物的消毒剂组合物
EA026955B1 (ru) * 2015-03-16 2017-06-30 Общество с ограниченной ответственностью "ФАРМА-ПОКРОВ" Дезинфицирующая композиция
JP6639099B2 (ja) * 2015-03-24 2020-02-05 花王株式会社 酸化性組成物
CA3067556A1 (en) * 2017-06-15 2018-12-20 Decon7 Systems, Llc Decontamination formulation
CA3069008A1 (en) * 2017-07-17 2019-01-24 Tiax Llc Neutralization compositions and methods for their use
CN111868220A (zh) * 2018-01-17 2020-10-30 涤康7号系统股份公司 洗衣净化配制物
CN110150279B (zh) * 2019-06-03 2023-08-25 南通思锐生物科技有限公司 一种即时快速生成过氧乙酸消毒剂的配制方法
CN111388935B (zh) * 2020-04-29 2021-10-01 中国人民解放军陆军防化学院 一种耐低温泡沫洗消剂及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901819A (en) * 1972-09-14 1975-08-26 Kao Corp Compositions for activating an inorganic peroxide bleaching agent
US4850729A (en) * 1987-04-07 1989-07-25 David N. Kramer Decontaminating composition and delivery system therefor
EP0894512A1 (de) * 1997-07-31 1999-02-03 Irdec S.A. Verwendung von stabilisierten entseuchenden Zusammensetzungen zur Dekontamination von Gift- und/oder Schadstoffen
FR2766724A1 (fr) * 1997-07-31 1999-02-05 Irdec Sa Compositions decontaminantes non agressives

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US366A (en) * 1837-08-31 Quadrant hinge foe
US3810788A (en) * 1966-02-15 1974-05-14 P Steyermark Method for decontaminating chemical warfare agents
US3852210A (en) * 1972-08-11 1974-12-03 Flow Pharma Inc Stable liquid detergent concentrates containing active oxygen
GB8304990D0 (en) * 1983-02-23 1983-03-30 Procter & Gamble Detergent ingredients
JPH0617289B2 (ja) * 1985-12-27 1994-03-09 エーザイ株式会社 蓄舎用殺菌剤組成物
JPS6390586A (ja) * 1986-09-29 1988-04-21 リ−・フア−マス−テイカルズ・インコ−ポレイテツド 改良された接着タブ系
USH366H (en) * 1987-03-18 1987-11-03 The United States Of America As Represented By The Secretary Of The Army Microemulsions containing sulfolanes
US5387717A (en) * 1992-08-12 1995-02-07 Buckman Laboratories International, Inc. Method for the detoxification of mustard gas, sulfur-containing quaternary ammonium ionene polymers and their use as microbicides
US5421906A (en) * 1993-04-05 1995-06-06 Enclean Environmental Services Group, Inc. Methods for removal of contaminants from surfaces
US5760089A (en) * 1996-03-13 1998-06-02 The United States Of America As Represented By The Secretary Of The Navy Chemical warfare agent decontaminant solution using quaternary ammonium complexes
JP4498475B2 (ja) * 1996-06-26 2010-07-07 花王株式会社 液体漂白剤組成物
JPH1088192A (ja) * 1996-09-10 1998-04-07 Sekisui Chem Co Ltd 漂白洗浄剤組成物
US6245957B1 (en) * 1999-09-02 2001-06-12 The United States Of America As Represented By The Secretary Of The Army Universal decontaminating solution for chemical warfare agents
ATE407192T1 (de) * 2000-02-23 2008-09-15 Procter & Gamble Waschmittelgranulate enthaltend zwitterionische polyamine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901819A (en) * 1972-09-14 1975-08-26 Kao Corp Compositions for activating an inorganic peroxide bleaching agent
US4850729A (en) * 1987-04-07 1989-07-25 David N. Kramer Decontaminating composition and delivery system therefor
EP0894512A1 (de) * 1997-07-31 1999-02-03 Irdec S.A. Verwendung von stabilisierten entseuchenden Zusammensetzungen zur Dekontamination von Gift- und/oder Schadstoffen
FR2766724A1 (fr) * 1997-07-31 1999-02-05 Irdec Sa Compositions decontaminantes non agressives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03028429A2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3337325A4 (de) * 2015-07-17 2019-02-13 Next Science IP Holdings Pty Ltd Antimikrobielle zusammensetzung mit wirksamkeit gegen endosporen
EP4011210A1 (de) * 2015-07-17 2022-06-15 Next Science IP Holdings Pty Ltd Verwendung von einer antimikrobiellen zusammensetzung mit wirksamkeit gegen endosporen

Also Published As

Publication number Publication date
IL161200A (en) 2007-09-20
EP1434625A4 (de) 2010-07-21
CN1612766A (zh) 2005-05-04
BR0213019A (pt) 2004-10-05
IL161200A0 (en) 2004-08-31
WO2003028429A3 (en) 2003-12-18
JP2005504856A (ja) 2005-02-17
KR20040048923A (ko) 2004-06-10
AU2002341750B2 (en) 2007-10-11
HK1073618A1 (en) 2005-10-14
JP4582514B2 (ja) 2010-11-17
BR0213019B1 (pt) 2011-12-27
KR100916328B1 (ko) 2009-09-11
EA200400500A1 (ru) 2004-10-28
EP1434625B1 (de) 2018-07-18
WO2003028429A2 (en) 2003-04-10
MXPA04003037A (es) 2005-07-01
CA2461872C (en) 2013-11-26
CN1612766B (zh) 2010-10-13
CA2461872A1 (en) 2003-04-10
EA009242B1 (ru) 2007-12-28

Similar Documents

Publication Publication Date Title
US7282470B2 (en) Decontamination formulation with sorbent additive
US7390432B2 (en) Enhanced formulations for neutralization of chemical, biological and industrial toxants
WO2005055963A2 (en) Decontamination formulation with sorbent additive
CA2461872C (en) Enhanced formulations for neutralization of chemical, biological and industrial toxants
AU2002341750A1 (en) Enhanced formulations for neutralization of chemical, biological and industrial toxants
US7064241B2 (en) Chemical and biological warfare decontaminating solution using peracids and germinants in microemulsions, process and product thereof
US6723890B2 (en) Concentrated formulations and methods for neutralizing chemical and biological toxants
EP1154820B1 (de) Breitspektrum dekontaminierung formulierung und verfahren zur deren verwendung
US20050109981A1 (en) Decontamination formulations for disinfection and sterilization
US8241562B1 (en) Enhanced toxic cloud knockdown spray system for decontamination applications
US7125497B1 (en) Reactive formulations for a neutralization of toxic industrial chemicals
US7662759B1 (en) Decontamination formulation with additive for enhanced mold remediation
US7531132B1 (en) Chemical and biological warfare agent decontaminating methods using dioxirane producing formulations
Tucker et al. Decontamination formulation with sorbent additive
TW589179B (en) Enhanced formulations for neutralization of chemical, biological and industrial toxants
Tucker Granulated decontamination formulations
RU2484869C2 (ru) Деконтаминирующий и пенообразующий водный раствор

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17P Request for examination filed

Effective date: 20040618

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1069786

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20100623

17Q First examination report despatched

Effective date: 20101228

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1069786

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180102

RAX Requested extension states of the european patent have changed

Extension state: LT

Extension state: MK

Extension state: AL

Extension state: SI

Extension state: LV

Extension state: RO

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

INTC Intention to grant announced (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SAN

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

INTG Intention to grant announced

Effective date: 20180522

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1018731

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180815

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60249522

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180718

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1018731

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180718

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181019

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181018

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNGEN

RIC2 Information provided on ipc code assigned after grant

Ipc: A62D 3/00 20060101AFI20040517BHEP

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60249522

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180930

26N No opposition filed

Effective date: 20190423

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180718

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20210812

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20210810

Year of fee payment: 20

Ref country code: GB

Payment date: 20210811

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60249522

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20220919

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20220919